The “hump” seen in the prevalence of prostate cancer in the 1990s (Figure 2A) may be explained by the increased diagnosis of prostate cancer after the prostate-specific antigen (PSA) test became available in the late 1980s [18] and actively promoted in the early-to-mid 1990s [19]. This evidence concerns the gene KLK3 and prostate cancer.